Close Menu
Home » Myriad Pushing Ahead With Payors on GeneSight as Data From Large Randomized Study is Published

Myriad Pushing Ahead With Payors on GeneSight as Data From Large Randomized Study is Published

Jan 07, 2019
|
Turna Ray

NEW YORK (GenomeWeb) – Myriad Genetics is hoping that data from a large randomized controlled study published last week on GeneSight will change the reimbursement prospects for the pharmacogenetic test, as well as shift the standard of care for treating depression.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Google's Health Info Gathering

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

'Bias Throughout the Pipeline'

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

Against the Plan

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

PNAS Papers Explore tRNA Fragment Signature in CLL, UV Hypermutated Melanocyte Sites, More

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.